Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Napa Jiratjintana"'
Autor:
Napa Jiratjintana, Natchaya Vanwong, Yaowaluck Hongkaew, Chonlaphat Sukasem, Weerapon Unaharassamee, Apichaya Puangpetch, Chalitpon Na Nakorn
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:806-813
Background The use of Atypical antipsychotics (AAPs) is related to metabolic disturbances, which put psychiatric patients at risk for cardiovascular morbidity and mortality. Evidence is emerging of genetic risk factors. The HTR2C gene is an essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::816754d635f02dd1254c923dd8953cfa
https://doi.org/10.1002/pds.5224
https://doi.org/10.1002/pds.5224
Autor:
Pornpen Srisawasdi, Martin H. Kroll, Chonlaphat Sukasem, Apichaya Puangpetch, Chalitpon Na Nakorn, Suweejuk Punprasit, Napa Jiratjintana, Somlak Vanavanan, Weerapon Unaharassamee
Publikováno v:
Pharmacogenomics and Personalized Medicine. 12:155-166
Objective To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter (LEP) rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00d82143d610e88b2b415a14f0dd841e
https://doi.org/10.2147/pgpm.s210770
https://doi.org/10.2147/pgpm.s210770
Autor:
Natchaya, Vanwong, Apichaya, Puangpetch, Weerapon, Unaharassamee, Napa, Jiratjintana, Chalitpon, Na Nakorn, Yaowaluck, Hongkaew, Chonlaphat, Sukasem
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 30(6)
The use of Atypical antipsychotics (AAPs) is related to metabolic disturbances, which put psychiatric patients at risk for cardiovascular morbidity and mortality. Evidence is emerging of genetic risk factors. The HTR2C gene is an essential candidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6c56c8642ff18084fa10bc654ac2069
https://pubmed.ncbi.nlm.nih.gov/33683783
https://pubmed.ncbi.nlm.nih.gov/33683783
Autor:
Napa Jiratjintana, Apichaya Puangpetch, Yaowaluck Hongkaew, Chonlaphat Sukasem, Chalitpon Na Nakorn, Natchaya Vanwong, Weerapon Unaharassamee
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 10
Journal of Personalized Medicine, Vol 11, Iss 943, p 943 (2021)
Volume 11
Issue 10
Journal of Personalized Medicine, Vol 11, Iss 943, p 943 (2021)
Background: Patients with psychotic disorders who receive atypical antipsychotic drugs often develop metabolic abnormalities. The sterol regulatory element-binding factor 2 (SREBF2) gene and insulin-induced gene (INSIG) have important roles in lipid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1262ce2a373b8c02dd4dd7ac352e38d4
https://doi.org/10.3390/jpm11100943
https://doi.org/10.3390/jpm11100943
Autor:
Chonlaphat Sukasem, Apichaya Puangpetch, Weerapon Unaharassamee, Napa Jiratjintana, Napatrupron Koomdee
Publikováno v:
The Journal of pharmacy and pharmacology. 70(4)
Objective Single nucleotide polymorphisms in serotonin 2C receptor (HTR2C), leptin (LEP), and leptin receptor (LEPR) genes are reportedly associated with the presence of metabolic syndrome (MS). We investigated whether HTR2C:rs518147 (-697G/C), rs128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ce65a11a258334297995bf613a09e2
https://pubmed.ncbi.nlm.nih.gov/29441581
https://pubmed.ncbi.nlm.nih.gov/29441581
Autor:
Apichaya Puangpetch, Weerapon Unaharassamee, Napa Jiratjintana, Napatrupron Koomdee, Chonlaphat Sukasem
Publikováno v:
Journal of Pharmacy & Pharmacology; Apr2018, Vol. 70 Issue 4, p536-542, 7p